Japanese Healthtech Stock News

How the CEO’s Warning Puts Toyota Motor (TSE:7203) in Focus Toyota Motor (TSE:7203) is back in the spotlight after its CEO warned that rapid progress by Chinese electric vehicle makers could threaten the company’s survival without major productivity changes. See our latest analysis for Toyota Motor. The share price has recently lost momentum, with a 1-day share price return of a 1.79% decline and a 90-day share price return of a 15.37% decline, even as the 1-year total shareholder return...

If you are wondering whether Daiichi Life Group's current share price reflects its underlying value, this article walks through what the numbers are really saying about the stock. The share price most recently closed at ¥1,410.5, with returns of 5.7% year to date and 48.6% over 1 year. Meanwhile, the 7 day and 30 day returns of a 3.4% decline and a 1.9% decline hint at a more mixed short term picture. Recent coverage has focused on Daiichi Life Group's role within the Japanese insurance...

If you are wondering whether OMRON is priced attractively right now, the recent share performance and a mixed valuation picture make it a stock worth a closer look. The share price closed at ¥5,093, with returns of 1.9% over 7 days, 13.0% over 30 days, 27.5% year to date and 21.5% over 1 year. This compares with declines of 31.8% over 3 years and 33.1% over 5 years. Recent news around OMRON has focused on the company as a key name in Japan's technology sector. This helps frame how investors...

If you are wondering whether Sony Group's current share price reflects its true worth, this breakdown will help you separate price from value. The stock recently closed at ¥3,208, with returns of a 5.5% decline over 7 days, a 0.3% decline over 30 days, a 21.4% decline year to date, but gains of 33.7% over 3 years and 59.3% over 5 years. Recent headlines have focused on Sony Group's position across entertainment, gaming and electronics, as well as its role in content and technology...

Latest FY 2026 Results Snapshot Nomura Research Institute (TSE:4307) has just capped FY 2026 with fourth quarter revenue of ¥212.4b and a basic EPS loss of ¥118.43, a sharp contrast to the trailing twelve month EPS of ¥26.62 and net income of ¥15.3b. Over the past several quarters, revenue has moved from ¥196.6b in Q4 FY 2025 to ¥195.8b, ¥201.3b and ¥205.3b, before reaching ¥212.4b in Q4 FY 2026. Quarterly basic EPS shifted from ¥38.40 to ¥45.43, ¥48.09 and ¥51.68, ahead of the latest...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Shimano Inc. ( TSE:7309 ) just released its first-quarter report and things are looking bullish. It was overall a...

Fanuc (TSE:6954) closed out FY 2026 with fourth quarter revenue of ¥234.5b and basic EPS of ¥53.24, set against trailing 12 month revenue of ¥857.8b and EPS of ¥178.47. Earnings over the past year improved 12.9% with forecasts pointing to about 7.4% annual growth. Over recent periods the company has seen quarterly revenue move from ¥197.1b in FY 2025 Q3 to ¥234.5b in FY 2026 Q4, with basic EPS over those same quarters ranging from ¥35.21 to ¥53.24. Trailing net margin held at 19.4% versus...

Renesas Electronics (TSE:6723) opened Q1 2026 with revenue of ¥380.3 billion and basic EPS of ¥37.57, while trailing twelve month EPS sits at a loss of ¥5.31, underlining that the latest quarterly profit is set against a still-unprofitable year. The company has seen quarterly revenue move from ¥292.6 billion in Q4 2024 to ¥380.3 billion in Q1 2026, with basic EPS ranging from a loss of ¥33.38 in Q2 2025 to ¥58.66 in Q3 2025. Investors are watching how consistently these margins can hold up...

It's been a mediocre week for Canon Inc. ( TSE:7751 ) shareholders, with the stock dropping 10% to JP¥4,024 in the week...

Nomura Holdings (TSE:8604) has wrapped up FY 2026 with fourth quarter revenue of ¥577.2b and basic EPS of ¥25.29, setting the tone for how investors assess the latest earnings run. Over recent periods, revenue has moved from ¥452.7b in FY 2025 Q4 to ¥577.2b in FY 2026 Q4, while quarterly basic EPS shifted from ¥24.35 to ¥25.29. On a trailing twelve month basis, EPS and net income reached ¥123.08 and ¥362.1b respectively, supported by revenue of ¥2.17t. With a trailing net margin of 16.7%...

Tokyo Steel Manufacturing (TSE:5423) has wrapped up FY 2026 with fourth quarter revenue of ¥66.2b and basic EPS of ¥21.05, setting the tone for a year where trailing twelve month revenue came in at ¥268.1b and EPS at ¥112.55. Over recent periods the company has seen quarterly revenue move from ¥80.4b and EPS of ¥66.02 in FY 2025 Q3 to ¥73.1b and EPS of ¥36.18 in FY 2026 Q1, before settling at FY 2026 Q4 levels. This frames a year where investors are likely to focus on how thinner margins and...

Why Metaplanet Stock Is Drawing Fresh Attention Metaplanet (TSE:3350) is back on investors’ radar after a recent pullback, with the share price down 3.7% over the past day and 1.7% over the past week, inviting closer scrutiny of its mixed return profile. See our latest analysis for Metaplanet. While the share price is currently at ¥339.0 after a 9.71% 1 month share price return and a 27.56% year to date share price decline, the very large 3 year total shareholder return suggests earlier...

Chugai Pharmaceutical (TSE:4519) opened 2026 with Q1 revenue of ¥321,747 million and basic EPS of ¥70.13, setting the tone off the back of a year where trailing twelve month revenue reached about ¥1.29 trillion and EPS came in at ¥274.77. Over recent quarters the company has seen revenue move from ¥288,459 million and EPS of ¥59.09 in Q1 2025 to ¥346,301 million and EPS of ¥78.04 in Q4 2025, giving you a clear view of the top line and per share earnings trend heading into the latest print...

Recent performance snapshot Inpex (TSE:1605) has drawn attention after a 2.6% gain over the past day and 2.2% over the past week, in contrast with an 8.3% decline over the past month but a 26.1% rise over the past 3 months. See our latest analysis for Inpex. The recent pullback, including a 1 month share price return of negative 8.3%, sits against a stronger backdrop. A 3 month share price return of 26.1% and a 1 year total shareholder return above 100% suggest that momentum has been building...

If you are wondering whether Eisai is starting to look attractively priced or still expensive, the recent share performance gives you a useful starting point. The stock closed at ¥4,735, with a 20.0% return over the last year. Shorter term moves show a 3.2% decline over 7 days, a 2.8% decline over 30 days, and a 1.1% decline year to date, which hints at shifting views on its risk and reward profile. Recent company updates, including progress on its pharmaceutical pipeline and ongoing...

Recent returns and business snapshot Asahi Group Holdings (TSE:2502) has recently drawn attention after a stretch of mixed share returns, including a 0.6% decline in the latest session and weaker performance over the past year. The company operates a broad beverage and food portfolio across Japan, Europe, Oceania, and Southeast Asia, generating revenue of ¥2,926,294 and net income of ¥155,563, with annual revenue growth of 3.9% and net income growth of 10.3%. See our latest analysis for Asahi...

If you are wondering whether Mitsui's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current numbers say. Mitsui recently closed at ¥5,784, with a 1-year return of 110.0%, a 3-year return of 197.3% and a very large 5-year gain. However, the stock has seen a 0.3% decline over 7 days and a 7.5% decline over 30 days, while the year-to-date return stands at 21.7%. Recent coverage has focused on Mitsui's...

Last week, you might have seen that BRONCO BILLY Co.,LTD. ( TSE:3091 ) released its quarterly result to the market. The...

As you might know, Disco Corporation ( TSE:6146 ) just kicked off its latest annual results with some very strong...

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...

Dai Nippon Printing Co., Ltd. has announced it will begin mass production in April 2026 of a new decorative film for automotive displays that combines woodgrain-style design with advanced optical performance, initially targeting the Chinese market before moving into Europe, Japan, the United States, South Korea, India and other regions. An interesting angle is DNP’s plan to apply this microfabricated, Electron Beam-coated film beyond car interiors, including exterior auto components and...

Nintendo recently reported rising memory component costs that it cannot pass on to customers, pressuring margins and forcing a cut in quarterly Switch 2 production from 6 million to 4 million units amid softer demand. An interesting angle is that, despite these operational headwinds, the company is leaning on its sizeable cash reserves to support its longer-term business plans. We’ll now explore how rising memory costs and reduced Switch 2 production are shaping Nintendo’s investment...

If you are wondering whether Toyota Tsusho at ¥6,100 still offers value, the key is understanding how its current price lines up with different valuation checks. The stock is up 10.8% year to date, with a 142.7% return over the past year, even though the last 7 and 30 days show modest declines of 2.3% and 2.1%. Recent coverage has focused on Toyota Tsusho as part of broader discussions around major Japanese trading houses and their roles in global supply chains, resource sourcing, and...